CClinicalTrials.gg
CompletedNCT05827094Mindful MealsUpdated Mar 13, 2025Results posted

Pilot Mobile for Dementia and Frailty

An interventional study of Mobile app and Usual Care in Dementia and Frailty, sponsored by University of Washington. Completed at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-03-13.

Sponsored by University of Washington · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
19
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

In this project, we propose to build on our Stage I formative work (according to the NIH Stage Model for Behavioral Intervention Development), where we developed fully functional prototypes of a mobile intervention aimed at improving adherence to Mediterranean Diet (MedD) for older adults with frailty and early dementia to complete the Stage II exploratory work, where the intervention will undergo further feasibility, acceptability, and preliminary efficacy tests. The intervention includes a patient-facing app that allows users to track their diet and receive personalized feedback concerning opportunities for improvement and recipes for breakfast, lunch, dinner, and snacks, informational materials about MedD, and a chat feature. On the other end, a web-based provider interface allows clinicians to review patient progress, suggest meal plans, and send and receive messages. The pilot randomized controlled trial, conducted over three months, will compare usual care to usual care plus mobile intervention to gather preliminary efficacy data concerning a change in adherence to MedD score (primary outcome). Mechanistic and secondary outcomes will include MedD knowledge, constructs from Social Cognitive Theory (self-efficacy, outcome expectation, self-regulation, and social support), platform use, anthropometric, and functional measures. Feasibility will be evaluated in terms of recruitment and retention outcomes. Acceptability will be determined through post-intervention semi-structured interviews and structured survey measures.

02

Conditions studied

  • Dementia
  • Frailty

Keywords

  • Diet
  • Nutrition
  • Mediterranean Diet
03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.

This study's enrollment of 19 is below the median of 83 across 1,629 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

University of Washington is the lead sponsor of 1,397 studies on the registry; 225 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 132 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. 65 years or older;
  2. ICD-9-CM (ICD-10-CM) codes for mild or major neurocognitive disorders with mild-to-moderate severity due to several possible etiologies. Specifically, a) mild neurocognitive disorder 331.83 (G31.84); major neurocognitive disorder 294.1x (F02.8x) due to Alzheimer disease 331.0 (G30.9); frontotemporal lobar degeneration 331.19 (G31.09); Lewy body disease 331.82 (G31.83);
  3. mild-to-moderate frailty
  4. own a mobile device.

Exclusion criteria

Exclusion Criteria:

  1. Severe sensory impairment that makes it impossible to operate a mobile device or respond to prompts
  2. English reading level below 6th grade
  3. no care partner
  4. optimal diet
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
19 participants (actual)

Study arms

  • Experimental
    Mobile Intervnetion

    Participants randomized to the intervention arm will receive verbal and written instructions as well as one-on-one demonstration of the app features. Participants will have an option of either receiving the study mobile device or will be able to use their own device with an installed app. Following the training, participants will be asked to use the app at least once a week.

    Other: Mobile app

  • Active comparator
    Usual Care

    Participants randomly allocated to the control group will receive educational materials on healthy eating, as provided on the NIA web page (https://www.nia.nih.gov/health/healthy-eating).

    Other: Usual Care

Interventions

  • OtherMobile app

    The main mobile intervention features. Tracking and immediate feedback: Pressing the icon launches a short series of questions with multiple-choice response options focusing on recent meals . The survey items are modeled after the 14-item Mediterranean Adherence Screener using simplified language and intuitive visuals to lower cognitive load. Based on responses to the survey, the app provides an intuitive visualization of the survey results, personalized feedback, and recipes on how to improve the person's diet. On-demand resources: individuals are able to access on-demand resources about the MedD diet, its benefits, and best dietary practices. The recipe page includes a personalized list of simple breakfast, lunch, dinner, and snack recipes based on the survey results with step by step instructions on how to prepare Mediterranean foods. In-app messaging: Individuals are able to receive notifications and send and receive messages.

  • OtherUsual Care

    Participants randomly allocated to the control group will receive educational materials on healthy eating, as provided on the NIA web page (https://www.nia.nih.gov/health/healthy-eating).

06

What researchers measure

Primary outcomes

  1. Change in Adherence to Mediterranean Diet (aMed) Score. The Change Was Calculated From Two Time Points as the Value at the Later Time Point Minus the Value at the Earlier Time Point

    Mediterranean Diet adherence was measured using an Food Frequency Questionnaire (FFQ) adherence to Mediterranean Diet (aMED) score. The self-administered FFQ asks participants to report the frequency of consumption and portion size of approximately 125-line items over the last 3 months. A series of foods or beverages define each line item. The aMED score was designed to assess adherence to a Mediterranean dietary pattern. aMED scores range from 0 (nonadherence) to 9 (perfect adherence)

    Time frame: Baseline; 12 weeks

Secondary outcomes

  1. Short Physical Performance Battery

    The Short Physical Performance Battery (SPPB) is designed to measure functional status and physical performance. The scale is a composite measure assessing walking speed, standing balance, and sit-to-stand performance. The three tests are summed to give a total score, with a maximum of 12 and a minimum of 0, with a higher score indicating higher function.

    Time frame: Baseline; 12 weeks

  2. Mediterranean Diet Nutrition Knowledge (MDNK) Questionnaire

    Items include questions focused on knowledge about foods and nutrients that are important in the MedD.

    Time frame: Baseline; 12 weeks

  3. Waist Circumference (WC)

    WC at the natural waist or narrowest part of the torso will also be measured to the nearest 0.1 cm

    Time frame: Baseline; 12 weeks

  4. Body Mass Index

    Weight to the nearest 0.1 kg and height to the nearest 0.1 cm will be measured and used to compute BMI.

    Time frame: Baseline; 12 weeks

  5. Social Cognitive Theory

    Social-cognitive theory (SCT) mechanistic variables will be measured using the Food Beliefs Survey and modified to focus on MedD

    Time frame: Baseline; 12 weeks

07

Results

Posted Mar 13, 2025

Participant flow

Participant flow — Overall Study
MilestoneMobileControl
Started109
Completed99
Not completed10

Outcome measures

PrimaryChange in Adherence to Mediterranean Diet (aMed) Score. The Change Was Calculated From Two Time Points as the Value at the Later Time Point Minus the Value at the Earlier Time Point

Mediterranean Diet adherence was measured using an Food Frequency Questionnaire (FFQ) adherence to Mediterranean Diet (aMED) score. The self-administered FFQ asks participants to report the frequency of consumption and portion size of approximately 125-line items over the last 3 months. A series of foods or beverages define each line item. The aMED score was designed to assess adherence to a Mediterranean dietary pattern. aMED scores range from 0 (nonadherence) to 9 (perfect adherence)

Time frame:
Baseline; 12 weeks
Reported as:
Mean · score on a scale
Change in Adherence to Mediterranean Diet (aMed) Score. The Change Was Calculated From Two Time Points as the Value at the Later Time Point Minus the Value at the Earlier Time Point
score on a scaleMobile IntervnetionUsual Care
Change in Adherence to Mediterranean Diet (aMed) Score. The Change Was Calculated From Two Time Points as the Value at the Later Time Point Minus the Value at the Earlier Time Point0 ± 2-0.2 ± 1
SecondaryShort Physical Performance Battery

The Short Physical Performance Battery (SPPB) is designed to measure functional status and physical performance. The scale is a composite measure assessing walking speed, standing balance, and sit-to-stand performance. The three tests are summed to give a total score, with a maximum of 12 and a minimum of 0, with a higher score indicating higher function.

Time frame:
Baseline; 12 weeks

Results for this outcome have not been posted.

SecondaryMediterranean Diet Nutrition Knowledge (MDNK) Questionnaire

Items include questions focused on knowledge about foods and nutrients that are important in the MedD.

Time frame:
Baseline; 12 weeks

Results for this outcome have not been posted.

SecondaryWaist Circumference (WC)

WC at the natural waist or narrowest part of the torso will also be measured to the nearest 0.1 cm

Time frame:
Baseline; 12 weeks

Results for this outcome have not been posted.

SecondaryBody Mass Index

Weight to the nearest 0.1 kg and height to the nearest 0.1 cm will be measured and used to compute BMI.

Time frame:
Baseline; 12 weeks

Results for this outcome have not been posted.

SecondarySocial Cognitive Theory

Social-cognitive theory (SCT) mechanistic variables will be measured using the Food Beliefs Survey and modified to focus on MedD

Time frame:
Baseline; 12 weeks

Results for this outcome have not been posted.

Adverse events

Collected over 3 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Mobile0/10 (0%)0/10 (0%)0/10 (0%)
Control0/9 (0%)0/9 (0%)0/9 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Mobile InterventionUsual CareTotal
Mean75 ± 974 ± 774 ± 8
Sex: Female, Male
Sex: Female, Male(Participants)Mobile InterventionUsual CareTotal
Female426
Male6713
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Mobile InterventionUsual CareTotal
American Indian or Alaska Native000
Asian101
Native Hawaiian or Other Pacific Islander000
Black or African American000
White9918
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Mobile InterventionUsual CareTotal
United States10919
08

Study locations

1 site
  • Univeristy of Washington
    Seattle, Washington 98195, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Apr 23, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05827094
Lead sponsor
University of Washington
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Responsible party
Oleg Zaslavsky (Associate Professor- School of Nursing, University of Washington) — Principal investigator
First posted
Apr 24, 2023
Start date
Jun 6, 2023
Primary completion
Mar 15, 2024
Completion
Mar 15, 2024
Results posted
Mar 13, 2025
Last update
Mar 13, 2025

Study contacts

Oleg Zaslavsky, PhD, MHA, RN
principal investigator · University of Washington

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion